B. Metzler seel. Sohn & Co’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.13M Sell
16,242
-134
-0.8% -$85.9K 0.08% 132
2025
Q4
$11.1M Sell
16,376
-571
-3% -$389K 0.1% 116
2025
Q3
$10.8M Sell
16,947
-4,388
-21% -$2.66M 0.1% 109
2025
Q2
$11.4M Buy
21,335
+1,017
+5% +$486K 0.11% 97
2025
Q1
$8.53M Buy
20,318
+5,761
+40% +$2.5M 0.09% 115
2024
Q4
$6.02M Buy
14,557
+5,322
+58% +$2.33M 0.06% 150
2024
Q3
$4.67M Buy
9,235
+215
+2% +$104K 0.05% 205
2024
Q2
$4.39M Buy
9,020
+122
+1% +$61.2K 0.04% 209
2024
Q1
$4.8M Sell
8,898
-10,643
-54% -$5.82M 0.05% 195
2023
Q4
$10.8M Buy
19,541
+2,796
+17% +$1.31M 0.14% 90
2023
Q3
$7.32M Buy
16,745
+1,637
+11% +$816K 0.11% 112
2023
Q2
$7.59M Buy
15,108
+10,428
+223% +$5M 0.1% 136
2023
Q1
$2.34M Sell
4,680
-862
-16% -$413K 0.04% 267
2022
Q4
$2.26M Sell
5,542
-1,396
-20% -$542K 0.04% 261
2022
Q3
$2.26M Sell
6,938
-3,099
-31% -$1.14M 0.04% 259
2022
Q2
$3.52M Buy
10,037
+1,239
+14% +$505K 0.06% 204
2022
Q1
$4.81M Buy
8,798
+468
+6% +$246K 0.06% 190
2021
Q4
$5.51M Buy
8,330
+3,030
+57% +$1.9M 0.07% 175
2021
Q3
$3.3M Sell
5,300
-97
-2% -$65.2K 0.05% 229
2021
Q2
$3.41M Buy
5,397
+153
+3% +$84.5K 0.05% 213
2021
Q1
$2.57M Buy
5,244
+89
+2% +$44.6K 0.04% 249
2020
Q4
$2.67M Buy
+5,155
New +$2.31M 0.05% 214

Other funds holding IDXX

B. Metzler seel. Sohn & Co's IDXX Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co reduced its Idexx Laboratories (IDXX) stake by 0.82% in Q1 2026, selling an estimated $85.9K and leaving 16,242 shares worth $9.13M. The position accounts for 0.08% of the portfolio, ranked #132.

B. Metzler seel. Sohn & Co first reported a position in IDXX in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.4M in Q2 2025. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 16,242 shares of Idexx Laboratories worth $9.13M as of Q1 2026.
  • B. Metzler seel. Sohn & Co sold 134 Idexx Laboratories shares in Q1 2026, an estimated $85.9K.
  • Idexx Laboratories made up 0.08% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #132 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Idexx Laboratories in Q4 2020 and has held it in 22 quarters since.
  • B. Metzler seel. Sohn & Co's Idexx Laboratories position peaked at $11.4M in Q2 2025.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.